Beyond Air
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Beyond Air and other ETFs, options, and stocks.About XAIR
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments.
CEOSteven A. Lisi
CEOSteven A. Lisi
Employees61
Employees61
HeadquartersGarden City, New York
HeadquartersGarden City, New York
Founded2015
Founded2015
Employees61
Employees61
XAIR Key Statistics
Market cap14.08M
Market cap14.08M
Price-Earnings ratio-0.16
Price-Earnings ratio-0.16
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today$1.82
High today$1.82
Low today$1.71
Low today$1.71
Open price$1.75
Open price$1.75
Volume200.35K
Volume200.35K
52 Week high$13.52
52 Week high$13.52
52 Week low$1.65
52 Week low$1.65
Stock Snapshot
Beyond Air(XAIR) stock is priced at $1.78, giving the company a market capitalization of 14.08M. It carries a P/E multiple of -0.16.
During the trading session on 2025-11-06, Beyond Air(XAIR) shares reached a daily high of $1.82 and a low of $1.71. At a current price of $1.78, the stock is +3.8% higher than the low and still -2.5% under the high.
Trading activity shows a volume of 200.35K, compared to an average daily volume of 2.12M.
The stock's 52-week range extends from a low of $1.65 to a high of $13.52.
The stock's 52-week range extends from a low of $1.65 to a high of $13.52.
XAIR News
TipRanks 19h
Beyond Air Secures $32 Million Financing AgreementMeet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
People also own
Based on the portfolios of people who own XAIR. This list is generated using Robinhood data, and it’s not a recommendation.